speb/financial-data huggingface dataset:
CTOR income_statement (annual, 2024-09-30) — Net Income From Continuing And Discontinued Operation: -21148747.00
CTOR income_statement (annual, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: -21148747.00
CTOR cash_flow (annual, 2024-09-30) — Net Income From Continuing Operations: -21148747.00
CTOR income_statement (annual, 2024-09-30) — Net Income Including Noncontrolling Interests: -21148747.00
CTOR cash_flow (annual, 2024-09-30) — Net Intangibles Purchase And Sale: -5000000.00
CTOR income_statement (annual, 2024-09-30) — Net Interest Income: 0.00
CTOR cash_flow (annual, 2024-09-30) — Net Issuance Payments Of Debt: 3800111.00
CTOR cash_flow (annual, 2024-09-30) — Net Long Term Debt Issuance: 3800111.00
CTOR income_statement (annual, 2024-09-30) — Net Non Operating Interest Income Expense: 0.00
CTOR cash_flow (annual, 2024-09-30) — Net Other Financing Charges: 1073648.00
CTOR balance_sheet (annual, 2024-09-30) — Net Tangible Assets: -27259661.00
CTOR balance_sheet (annual, 2024-09-30) — Non Current Deferred Liabilities: 1728000.00
CTOR balance_sheet (annual, 2024-09-30) — Non Current Deferred Taxes Liabilities: 1728000.00
CTOR income_statement (annual, 2024-09-30) — Normalized EBITDA: -20572747.00
CTOR income_statement (annual, 2024-09-30) — Normalized Income: -21148747.00
CTOR cash_flow (annual, 2024-09-30) — Operating Cash Flow: 126353.00
CTOR income_statement (annual, 2024-09-30) — Operating Income: -20572747.00
CTOR income_statement (annual, 2024-09-30) — Operating Revenue: 0.00
CTOR balance_sheet (annual, 2024-09-30) — Ordinary Shares Number: 71552402.00
CTOR balance_sheet (annual, 2024-09-30) — Other Current Liabilities: 1.00
CTOR balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 1.00
CTOR income_statement (annual, 2024-09-30) — Other Gand A: 8148929.00
CTOR balance_sheet (annual, 2024-09-30) — Other Intangible Assets: 73400000.00
CTOR balance_sheet (annual, 2024-09-30) — Other Non Current Liabilities: -1.00
CTOR balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: -1.00
CTOR balance_sheet (annual, 2024-09-30) — Other Payable: 28400000.00
CTOR balance_sheet (annual, 2024-09-30) — Payables: 32700428.00
CTOR balance_sheet (annual, 2024-09-30) — Payables And Accrued Expenses: 32700428.00
CTOR balance_sheet (annual, 2024-09-30) — Preferred Stock: 0.00
CTOR balance_sheet (annual, 2024-09-30) — Prepaid Assets: 2700000.00
CTOR income_statement (annual, 2024-09-30) — Pretax Income: -20572747.00
CTOR cash_flow (annual, 2024-09-30) — Purchase Of Intangibles: -5000000.00
CTOR income_statement (annual, 2024-09-30) — Research And Development: 4925001.00
CTOR balance_sheet (annual, 2024-09-30) — Retained Earnings: -39278587.00
CTOR income_statement (annual, 2024-09-30) — Salaries And Wages: 7498817.00
CTOR income_statement (annual, 2024-09-30) — Selling General And Administration: 15647746.00
CTOR balance_sheet (annual, 2024-09-30) — Share Issued: 71552402.00
CTOR cash_flow (annual, 2024-09-30) — Stock Based Compensation: 7498817.00
CTOR balance_sheet (annual, 2024-09-30) — Stockholders Equity: 46140339.00
CTOR balance_sheet (annual, 2024-09-30) — Tangible Book Value: -27259661.00
CTOR income_statement (annual, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
CTOR income_statement (annual, 2024-09-30) — Tax Provision: 576000.00
CTOR income_statement (annual, 2024-09-30) — Tax Rate For Calcs: 0.21
CTOR balance_sheet (annual, 2024-09-30) — Total Assets: 84368878.00
CTOR balance_sheet (annual, 2024-09-30) — Total Capitalization: 49940450.00
CTOR balance_sheet (annual, 2024-09-30) — Total Debt: 3800111.00
CTOR balance_sheet (annual, 2024-09-30) — Total Equity Gross Minority Interest: 46140339.00
CTOR income_statement (annual, 2024-09-30) — Total Expenses: 20572747.00
CTOR balance_sheet (annual, 2024-09-30) — Total Liabilities Net Minority Interest: 38228539.00
CTOR balance_sheet (annual, 2024-09-30) — Total Non Current Assets: 73400000.00
CTOR balance_sheet (annual, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 5528110.00
CTOR income_statement (annual, 2024-09-30) — Total Operating Income As Reported: -20572747.00
CTOR balance_sheet (annual, 2024-09-30) — Work In Process: 2133871.00
CTOR balance_sheet (quarterly, 2024-09-30) — Work In Process: 2133871.00
CTOR balance_sheet (annual, 2024-09-30) — Working Capital: -21731551.00
CTOR income_statement (quarterly, 2024-12-31) — Amortization: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Amortization Of Intangibles Income Statement: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Basic Average Shares: 71552402.00
CTOR income_statement (quarterly, 2024-12-31) — Basic EPS: -0.09
CTOR cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Change In Receivables: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 71552402.00
CTOR income_statement (quarterly, 2024-12-31) — Diluted EPS: -0.09
CTOR cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Gross Profit: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Interest Income: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CTOR balance_sheet (quarterly, 2024-12-31) — Net Debt: 3799999.00
CTOR cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
CTOR cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
CTOR income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CTOR income_statement (quarterly, 2025-03-31) — +Operating Expense: 7471312.00
CTOR income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
CTOR balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 7676310.00
CTOR balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 89308821.00
CTOR income_statement (quarterly, 2025-03-31) — Amortization: 0.00
CTOR cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 0.00
CTOR cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Basic Average Shares: 71552402.00
CTOR income_statement (quarterly, 2025-03-31) — Basic EPS: -0.11
CTOR cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 112.00
CTOR balance_sheet (quarterly, 2025-03-31) — Capital Stock: 7155.00
CTOR balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 112.00
CTOR balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 112.00
CTOR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 0.00
CTOR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
CTOR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 0.00
CTOR cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 1801733.00
CTOR cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 2493556.00
CTOR cash_flow (quarterly, 2025-03-31) — Change In Inventory: -957884.00
CTOR cash_flow (quarterly, 2025-03-31) — Change In Payable: 3847068.00
CTOR cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 6340624.00
CTOR cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 0.00
CTOR cash_flow (quarterly, 2025-03-31) — Change In Receivables: 0.00
CTOR cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 5382740.00
CTOR cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 0.00
CTOR balance_sheet (quarterly, 2025-03-31) — Common Stock: 7155.00
CTOR balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 35642632.00
CTOR cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 0.00
CTOR balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 8722168.00
CTOR balance_sheet (quarterly, 2025-03-31) — Current Assets: 18039365.00
CTOR balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 49740142.00
CTOR cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 264240.00
CTOR cash_flow (quarterly, 2025-03-31) — Deferred Tax: 264240.00
CTOR cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 0.00
CTOR cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 71552402.00
CTOR income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.11
CTOR income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -7735552.00
CTOR balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 4941664.00
CTOR income_statement (quarterly, 2025-03-31) — EBIT: -7471312.00
CTOR income_statement (quarterly, 2025-03-31) — EBITDA: -7471312.00
CTOR cash_flow (quarterly, 2025-03-31) — End Cash Position: 112.00
CTOR cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 0.00
CTOR cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 0.00
CTOR income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4331899.00
CTOR balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 73400000.00
CTOR income_statement (quarterly, 2025-03-31) — Gross Profit: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Interest Expense: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Interest Income: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 0.00
CTOR cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
CTOR balance_sheet (quarterly, 2025-03-31) — Inventory: 15339253.00
CTOR balance_sheet (quarterly, 2025-03-31) — Invested Capital: 39442743.00
CTOR cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
CTOR cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CTOR balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 3800111.00
CTOR balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3800111.00
CTOR cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CTOR balance_sheet (quarterly, 2025-03-31) — Net Debt: 3799999.00
CTOR income_statement (quarterly, 2025-03-31) — Net Income: -7735552.00
CTOR income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -7735552.00
CTOR income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -7735552.00
CTOR income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -7735552.00
CTOR income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -7735552.00
CTOR cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -7735552.00
CTOR income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -7735552.00
CTOR cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Net Interest Income: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 0.00
CTOR balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -37757368.00
CTOR balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 2256480.00
CTOR balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2256480.00
CTOR income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -7471312.00
CTOR income_statement (quarterly, 2025-03-31) — Normalized Income: -7735552.00
CTOR cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Operating Income: -7471312.00
CTOR income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
CTOR balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 71552402.00
CTOR income_statement (quarterly, 2025-03-31) — Other Gand A: 2243327.00
CTOR balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 73400000.00
CTOR balance_sheet (quarterly, 2025-03-31) — Other Payable: 28400000.00
CTOR balance_sheet (quarterly, 2025-03-31) — Payables: 41017974.00
CTOR balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 49740142.00
CTOR balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CTOR balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 2700000.00
CTOR income_statement (quarterly, 2025-03-31) — Pretax Income: -7471312.00
CTOR cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Research And Development: 3139413.00
CTOR balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -53673344.00
CTOR income_statement (quarterly, 2025-03-31) — Salaries And Wages: 2088572.00
CTOR income_statement (quarterly, 2025-03-31) — Selling General And Administration: 4331899.00
CTOR balance_sheet (quarterly, 2025-03-31) — Share Issued: 71552402.00
CTOR cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2088572.00
CTOR balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 35642632.00
CTOR balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -37757368.00
CTOR income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CTOR income_statement (quarterly, 2025-03-31) — Tax Provision: 264240.00
CTOR income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CTOR balance_sheet (quarterly, 2025-03-31) — Total Assets: 91439365.00
CTOR balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 39442743.00
CTOR balance_sheet (quarterly, 2025-03-31) — Total Debt: 3800111.00
CTOR balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 35642632.00
CTOR income_statement (quarterly, 2025-03-31) — Total Expenses: 7471312.00
CTOR balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 55796733.00
CTOR balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 73400000.00
CTOR balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 6056591.00
CTOR income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -7471312.00
CTOR balance_sheet (quarterly, 2025-03-31) — Working Capital: -31700777.00
CTOR income_statement (quarterly, 2025-06-30) — +Operating Expense: 4944961.00
CTOR income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
CTOR balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 8667419.00
CTOR balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 91434058.00
CTOR income_statement (quarterly, 2025-06-30) — Basic Average Shares: 71552402.00
CTOR income_statement (quarterly, 2025-06-30) — Basic EPS: -0.08
CTOR cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 112.00
CTOR balance_sheet (quarterly, 2025-06-30) — Capital Stock: 7155.00
CTOR balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 112.00
CTOR balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 112.00
CTOR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 0.00
CTOR cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 991109.00
CTOR cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -263614.00
CTOR cash_flow (quarterly, 2025-06-30) — Change In Inventory: -1869714.00
CTOR cash_flow (quarterly, 2025-06-30) — Change In Payable: 3513807.00
CTOR cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 3250193.00
CTOR cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1600000.00
CTOR cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 2980479.00
CTOR balance_sheet (quarterly, 2025-06-30) — Common Stock: 7155.00
CTOR balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 32397913.00
CTOR balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 8458554.00
CTOR balance_sheet (quarterly, 2025-06-30) — Current Assets: 18309079.00
CTOR balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 52990335.00
CTOR cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 264240.00
CTOR cash_flow (quarterly, 2025-06-30) — Deferred Tax: 264240.00
CTOR income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 71552402.00
CTOR income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.08
CTOR income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -5369956.00
CTOR balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 7464362.00
CTOR income_statement (quarterly, 2025-06-30) — EBIT: -4944961.00
CTOR income_statement (quarterly, 2025-06-30) — EBITDA: -4944961.00
CTOR cash_flow (quarterly, 2025-06-30) — End Cash Position: 112.00
CTOR cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 0.00
CTOR income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 4006684.00
CTOR balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 73400000.00
CTOR income_statement (quarterly, 2025-06-30) — Interest Expense: 160755.00
CTOR income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 160755.00
CTOR balance_sheet (quarterly, 2025-06-30) — Inventory: 17208967.00
CTOR balance_sheet (quarterly, 2025-06-30) — Invested Capital: 36198024.00
CTOR balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 3800111.00
CTOR balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 3800111.00
CTOR balance_sheet (quarterly, 2025-06-30) — Net Debt: 3799999.00
CTOR income_statement (quarterly, 2025-06-30) — Net Income: -5369956.00
CTOR income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -5369956.00
CTOR income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -5369956.00
CTOR income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -5369956.00
CTOR income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -5369956.00
CTOR cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -5369956.00
CTOR income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -5369956.00
CTOR income_statement (quarterly, 2025-06-30) — Net Interest Income: -160755.00
CTOR income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -160755.00
CTOR balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -41002087.00
CTOR balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 2520720.00
CTOR balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2520720.00
CTOR income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -4944961.00
CTOR income_statement (quarterly, 2025-06-30) — Normalized Income: -5369956.00
CTOR cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 0.00
CTOR income_statement (quarterly, 2025-06-30) — Operating Income: -4944961.00
CTOR income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
CTOR balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 71552402.00
CTOR income_statement (quarterly, 2025-06-30) — Other Gand A: 1881447.00
CTOR balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 73400000.00
CTOR balance_sheet (quarterly, 2025-06-30) — Other Payable: 28400000.00
CTOR balance_sheet (quarterly, 2025-06-30) — Payables: 44531781.00
CTOR balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 52990335.00
CTOR balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CTOR balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1100000.00
CTOR income_statement (quarterly, 2025-06-30) — Pretax Income: -5105716.00
CTOR income_statement (quarterly, 2025-06-30) — Research And Development: 938277.00
CTOR balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -59043300.00
CTOR income_statement (quarterly, 2025-06-30) — Salaries And Wages: 2125237.00
CTOR income_statement (quarterly, 2025-06-30) — Selling General And Administration: 4006684.00
CTOR balance_sheet (quarterly, 2025-06-30) — Share Issued: 71552402.00
CTOR cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2125237.00
CTOR balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 32397913.00
CTOR balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -41002087.00
CTOR income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CTOR income_statement (quarterly, 2025-06-30) — Tax Provision: 264240.00
CTOR income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CTOR balance_sheet (quarterly, 2025-06-30) — Total Assets: 91709079.00
CTOR balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 36198024.00
CTOR balance_sheet (quarterly, 2025-06-30) — Total Debt: 3800111.00
CTOR balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 32397913.00
CTOR income_statement (quarterly, 2025-06-30) — Total Expenses: 4944961.00
CTOR balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 59311166.00
CTOR balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 73400000.00
CTOR balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 6320831.00
CTOR income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -4944961.00
CTOR balance_sheet (quarterly, 2025-06-30) — Working Capital: -34681256.00
CTOR income_statement (annual, 2025-09-30) — +Operating Expense: 23522750.00
CTOR income_statement (quarterly, 2025-09-30) — +Operating Expense: 4711512.00
CTOR income_statement (annual, 2025-09-30) — +Total Revenue: 0.00
CTOR income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
CTOR balance_sheet (annual, 2025-09-30) — Accounts Payable: 13234684.00
CTOR balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 13234684.00
CTOR balance_sheet (annual, 2025-09-30) — Additional Paid In Capital: 108897836.00
CTOR balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 108897836.00
CTOR income_statement (annual, 2025-09-30) — Basic Average Shares: 73267969.00
CTOR income_statement (annual, 2025-09-30) — Basic EPS: -0.34
CTOR cash_flow (annual, 2025-09-30) — Beginning Cash Position: 112.00
CTOR cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 112.00
CTOR cash_flow (annual, 2025-09-30) — Capital Expenditure: -5750000.00
CTOR balance_sheet (annual, 2025-09-30) — Capital Stock: 8351.00
CTOR balance_sheet (quarterly, 2025-09-30) — Capital Stock: 8351.00
CTOR balance_sheet (annual, 2025-09-30) — Cash And Cash Equivalents: 3924908.00
CTOR balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 3924908.00
CTOR balance_sheet (annual, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3924908.00
CTOR balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3924908.00
CTOR cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Financing Activities: 15166842.00
CTOR cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Investing Activities: -5750000.00
CTOR cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Operating Activities: -5492046.00
CTOR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -5492046.00
CTOR cash_flow (annual, 2025-09-30) — Change In Account Payable: 9523062.00
CTOR cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 4567265.00
CTOR cash_flow (annual, 2025-09-30) — Change In Accrued Expense: 4093124.00
CTOR cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -4365430.00
CTOR cash_flow (annual, 2025-09-30) — Change In Inventory: -12649207.00
CTOR cash_flow (quarterly, 2025-09-30) — Change In Inventory: -3709006.00
CTOR cash_flow (annual, 2025-09-30) — Change In Payable: 18448027.00
CTOR cash_flow (quarterly, 2025-09-30) — Change In Payable: 6616674.00
CTOR cash_flow (annual, 2025-09-30) — Change In Payables And Accrued Expense: 22541151.00
CTOR cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2251244.00
CTOR cash_flow (annual, 2025-09-30) — Change In Prepaid Assets: 0.00
CTOR cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1600000.00
CTOR cash_flow (annual, 2025-09-30) — Change In Working Capital: 9891944.00
CTOR cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -3057762.00
CTOR cash_flow (annual, 2025-09-30) — Changes In Cash: 3924796.00
CTOR balance_sheet (annual, 2025-09-30) — Common Stock: 8351.00
CTOR balance_sheet (quarterly, 2025-09-30) — Common Stock: 8351.00
CTOR balance_sheet (annual, 2025-09-30) — Common Stock Equity: 44866231.00
CTOR balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 44866231.00
CTOR cash_flow (annual, 2025-09-30) — Common Stock Issuance: 15166842.00
CTOR balance_sheet (annual, 2025-09-30) — Current Accrued Expenses: 4093124.00
CTOR balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 4093124.00
CTOR balance_sheet (annual, 2025-09-30) — Current Assets: 27542881.00
CTOR balance_sheet (quarterly, 2025-09-30) — Current Assets: 27542881.00
CTOR balance_sheet (annual, 2025-09-30) — Current Liabilities: 49491579.00
CTOR balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 49491579.00
CTOR cash_flow (annual, 2025-09-30) — Deferred Income Tax: 1056960.00
CTOR cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 264240.00
CTOR cash_flow (annual, 2025-09-30) — Deferred Tax: 1056960.00
CTOR cash_flow (quarterly, 2025-09-30) — Deferred Tax: 264240.00
CTOR income_statement (annual, 2025-09-30) — Diluted Average Shares: 73267969.00
CTOR income_statement (annual, 2025-09-30) — Diluted EPS: -0.34
CTOR income_statement (annual, 2025-09-30) — Diluted NI Availto Com Stockholders: -24761369.00
CTOR income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -4996656.00
CTOR balance_sheet (annual, 2025-09-30) — Dueto Related Parties Current: 9513771.00
CTOR balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 9513771.00
CTOR income_statement (annual, 2025-09-30) — EBIT: -23486377.00
CTOR income_statement (quarterly, 2025-09-30) — EBIT: -4675139.00
CTOR income_statement (annual, 2025-09-30) — EBITDA: -23486377.00
CTOR income_statement (quarterly, 2025-09-30) — EBITDA: -4675139.00
CTOR cash_flow (annual, 2025-09-30) — End Cash Position: 3924908.00
CTOR cash_flow (quarterly, 2025-09-30) — End Cash Position: 3924908.00
CTOR cash_flow (annual, 2025-09-30) — Financing Cash Flow: 15166842.00
CTOR balance_sheet (annual, 2025-09-30) — Finished Goods: 10577876.00
CTOR balance_sheet (quarterly, 2025-09-30) — Finished Goods: 10577876.00
CTOR cash_flow (annual, 2025-09-30) — Free Cash Flow: -11242046.00
CTOR cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -11242046.00
CTOR income_statement (annual, 2025-09-30) — General And Administrative Expense: 17104416.00
CTOR income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 3635376.00
CTOR balance_sheet (annual, 2025-09-30) — Goodwill And Other Intangible Assets: 73400000.00
CTOR balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 73400000.00
CTOR income_statement (annual, 2025-09-30) — Interest Expense: 218032.00
CTOR income_statement (quarterly, 2025-09-30) — Interest Expense: 57277.00
CTOR income_statement (annual, 2025-09-30) — Interest Expense Non Operating: 218032.00
CTOR income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 57277.00
CTOR income_statement (annual, 2025-09-30) — Interest Income: 36373.00
CTOR income_statement (annual, 2025-09-30) — Interest Income Non Operating: 36373.00
CTOR balance_sheet (annual, 2025-09-30) — Inventory: 22286693.00
CTOR balance_sheet (quarterly, 2025-09-30) — Inventory: 22286693.00
CTOR balance_sheet (annual, 2025-09-30) — Invested Capital: 48666342.00
CTOR balance_sheet (quarterly, 2025-09-30) — Invested Capital: 48666342.00
CTOR cash_flow (annual, 2025-09-30) — Investing Cash Flow: -5750000.00
CTOR cash_flow (annual, 2025-09-30) — Issuance Of Capital Stock: 15166842.00
CTOR cash_flow (annual, 2025-09-30) — Issuance Of Debt: 0.00
CTOR balance_sheet (annual, 2025-09-30) — Long Term Debt: 3800111.00
CTOR balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 3800111.00
CTOR balance_sheet (annual, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 3800111.00
CTOR balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 3800111.00
CTOR cash_flow (annual, 2025-09-30) — Long Term Debt Issuance: 0.00
CTOR cash_flow (annual, 2025-09-30) — Net Common Stock Issuance: 15166842.00
CTOR income_statement (annual, 2025-09-30) — Net Income: -24761369.00
CTOR income_statement (quarterly, 2025-09-30) — Net Income: -4996656.00
CTOR income_statement (annual, 2025-09-30) — Net Income Common Stockholders: -24761369.00
CTOR income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -4996656.00
CTOR income_statement (annual, 2025-09-30) — Net Income Continuous Operations: -24761369.00
CTOR income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -4996656.00
CTOR income_statement (annual, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -24761369.00
CTOR income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -4996656.00
CTOR income_statement (annual, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -24761369.00
CTOR income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -4996656.00
CTOR cash_flow (annual, 2025-09-30) — Net Income From Continuing Operations: -24761369.00
CTOR cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -4996656.00
CTOR income_statement (annual, 2025-09-30) — Net Income Including Noncontrolling Interests: -24761369.00
CTOR income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -4996656.00
CTOR cash_flow (annual, 2025-09-30) — Net Intangibles Purchase And Sale: -5750000.00
CTOR income_statement (annual, 2025-09-30) — Net Interest Income: -181659.00
CTOR income_statement (quarterly, 2025-09-30) — Net Interest Income: -20904.00
CTOR cash_flow (annual, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
CTOR cash_flow (annual, 2025-09-30) — Net Long Term Debt Issuance: 0.00
CTOR income_statement (annual, 2025-09-30) — Net Non Operating Interest Income Expense: -181659.00
CTOR income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -20904.00
CTOR balance_sheet (annual, 2025-09-30) — Net Tangible Assets: -28533769.00
CTOR balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -28533769.00
CTOR balance_sheet (annual, 2025-09-30) — Non Current Deferred Liabilities: 2784960.00
CTOR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 2784960.00
CTOR balance_sheet (annual, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2784960.00
CTOR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2784960.00
CTOR income_statement (annual, 2025-09-30) — Normalized EBITDA: -23486377.00
CTOR income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -4675139.00
CTOR income_statement (annual, 2025-09-30) — Normalized Income: -24761369.00
CTOR income_statement (quarterly, 2025-09-30) — Normalized Income: -4996656.00
CTOR cash_flow (annual, 2025-09-30) — Operating Cash Flow: -5492046.00
CTOR cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -5492046.00
CTOR income_statement (annual, 2025-09-30) — Operating Income: -23522750.00
CTOR income_statement (quarterly, 2025-09-30) — Operating Income: -4711512.00
CTOR income_statement (annual, 2025-09-30) — Operating Revenue: 0.00
CTOR income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CTOR balance_sheet (annual, 2025-09-30) — Ordinary Shares Number: 83513442.00
CTOR balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 83513442.00
CTOR income_statement (annual, 2025-09-30) — Other Gand A: 8783997.00
CTOR income_statement (quarterly, 2025-09-30) — Other Gand A: 1337244.00
CTOR balance_sheet (annual, 2025-09-30) — Other Intangible Assets: 73400000.00
CTOR balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 73400000.00
CTOR balance_sheet (annual, 2025-09-30) — Other Payable: 22650000.00
CTOR balance_sheet (quarterly, 2025-09-30) — Other Payable: 22650000.00
CTOR balance_sheet (annual, 2025-09-30) — Payables: 45398455.00
CTOR balance_sheet (quarterly, 2025-09-30) — Payables: 45398455.00
CTOR balance_sheet (annual, 2025-09-30) — Payables And Accrued Expenses: 49491579.00
CTOR balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 49491579.00
CTOR balance_sheet (annual, 2025-09-30) — Preferred Stock: 0.00
CTOR balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CTOR balance_sheet (annual, 2025-09-30) — Prepaid Assets: 1331280.00
CTOR balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 1331280.00
CTOR income_statement (annual, 2025-09-30) — Pretax Income: -23704409.00
CTOR income_statement (quarterly, 2025-09-30) — Pretax Income: -4732416.00
CTOR cash_flow (annual, 2025-09-30) — Purchase Of Intangibles: -5750000.00
CTOR income_statement (annual, 2025-09-30) — Research And Development: 6418334.00
CTOR income_statement (quarterly, 2025-09-30) — Research And Development: 1076136.00
CTOR balance_sheet (annual, 2025-09-30) — Retained Earnings: -64039956.00
CTOR balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -64039956.00
CTOR income_statement (annual, 2025-09-30) — Salaries And Wages: 8320419.00
CTOR income_statement (quarterly, 2025-09-30) — Salaries And Wages: 2298132.00
CTOR income_statement (annual, 2025-09-30) — Selling General And Administration: 17104416.00
CTOR income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3635376.00
CTOR balance_sheet (annual, 2025-09-30) — Share Issued: 83513442.00
CTOR balance_sheet (quarterly, 2025-09-30) — Share Issued: 83513442.00
CTOR cash_flow (annual, 2025-09-30) — Stock Based Compensation: 8320419.00
CTOR cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2298132.00
CTOR balance_sheet (annual, 2025-09-30) — Stockholders Equity: 44866231.00
CTOR balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 44866231.00
CTOR balance_sheet (annual, 2025-09-30) — Tangible Book Value: -28533769.00
CTOR balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -28533769.00
CTOR income_statement (annual, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CTOR income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CTOR income_statement (annual, 2025-09-30) — Tax Provision: 1056960.00
CTOR income_statement (quarterly, 2025-09-30) — Tax Provision: 264240.00
CTOR income_statement (annual, 2025-09-30) — Tax Rate For Calcs: 0.21
CTOR income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CTOR balance_sheet (annual, 2025-09-30) — Total Assets: 100942881.00
CTOR balance_sheet (quarterly, 2025-09-30) — Total Assets: 100942881.00
CTOR balance_sheet (annual, 2025-09-30) — Total Capitalization: 48666342.00
CTOR balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 48666342.00
CTOR balance_sheet (annual, 2025-09-30) — Total Debt: 3800111.00
CTOR balance_sheet (quarterly, 2025-09-30) — Total Debt: 3800111.00
CTOR balance_sheet (annual, 2025-09-30) — Total Equity Gross Minority Interest: 44866231.00
CTOR balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 44866231.00
CTOR income_statement (annual, 2025-09-30) — Total Expenses: 23522750.00
CTOR income_statement (quarterly, 2025-09-30) — Total Expenses: 4711512.00
CTOR balance_sheet (annual, 2025-09-30) — Total Liabilities Net Minority Interest: 56076650.00
CTOR balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 56076650.00
CTOR balance_sheet (annual, 2025-09-30) — Total Non Current Assets: 73400000.00
CTOR balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 73400000.00
CTOR balance_sheet (annual, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 6585071.00
CTOR balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 6585071.00
CTOR income_statement (annual, 2025-09-30) — Total Operating Income As Reported: -23522750.00
CTOR income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -4711512.00
CTOR balance_sheet (annual, 2025-09-30) — Work In Process: 11708817.00
CTOR balance_sheet (quarterly, 2025-09-30) — Work In Process: 11708817.00
CTOR balance_sheet (annual, 2025-09-30) — Working Capital: -21948698.00
CTOR balance_sheet (quarterly, 2025-09-30) — Working Capital: -21948698.00
CTOR income_statement (quarterly, 2025-12-31) — +Operating Expense: 8407179.00
CTOR income_statement (quarterly, 2025-12-31) — +Total Revenue: 3944111.00
CTOR balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 10446900.00
CTOR balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 4049111.00
CTOR balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 127979246.00
CTOR balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
CTOR income_statement (quarterly, 2025-12-31) — Amortization: 573438.00
CTOR cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 573438.00
CTOR cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 573438.00
CTOR income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 573438.00
CTOR income_statement (quarterly, 2025-12-31) — Basic Average Shares: 87462385.00
CTOR income_statement (quarterly, 2025-12-31) — Basic EPS: -0.06
CTOR cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 3924908.00
CTOR cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -4400000.00
CTOR balance_sheet (quarterly, 2025-12-31) — Capital Stock: 8480.00
CTOR balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 7295451.00
CTOR balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 7295451.00
CTOR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 15125489.00
CTOR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4400000.00
CTOR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -7354946.00
CTOR cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -2787784.00
CTOR cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 425792.00
CTOR cash_flow (quarterly, 2025-12-31) — Change In Inventory: -352649.00
CTOR cash_flow (quarterly, 2025-12-31) — Change In Payable: -806977.00
CTOR cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -381185.00
CTOR cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1831660.00
CTOR cash_flow (quarterly, 2025-12-31) — Change In Receivables: -4049111.00
CTOR cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -6614605.00
CTOR cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -4049111.00
CTOR cash_flow (quarterly, 2025-12-31) — Changes In Cash: 3370543.00
CTOR balance_sheet (quarterly, 2025-12-31) — Common Stock: 8480.00
CTOR balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 58413701.00
CTOR cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 15125489.00
CTOR income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 789208.00
CTOR balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 4518916.00
CTOR balance_sheet (quarterly, 2025-12-31) — Current Assets: 37146844.00
CTOR balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 44710394.00
CTOR cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 264240.00
CTOR cash_flow (quarterly, 2025-12-31) — Deferred Tax: 264240.00
CTOR cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 573438.00
CTOR income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 573438.00
CTOR cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 573438.00
CTOR income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 573438.00
CTOR income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 87462385.00
CTOR income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.06
CTOR income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -5534069.00
CTOR balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 11494578.00
CTOR income_statement (quarterly, 2025-12-31) — EBIT: -5223988.00
CTOR income_statement (quarterly, 2025-12-31) — EBITDA: -4650550.00
CTOR cash_flow (quarterly, 2025-12-31) — End Cash Position: 7295451.00
CTOR cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 15125489.00
CTOR balance_sheet (quarterly, 2025-12-31) — Finished Goods: 15687377.00
CTOR cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -11754946.00
CTOR income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 6815389.00
CTOR balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 72826562.00
CTOR balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 4049111.00
CTOR income_statement (quarterly, 2025-12-31) — Gross Profit: 3154903.00
CTOR income_statement (quarterly, 2025-12-31) — Interest Expense: 45841.00
CTOR income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 45841.00
CTOR income_statement (quarterly, 2025-12-31) — Interest Income: 28288.00
CTOR income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 28288.00
CTOR cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 14460.00
CTOR balance_sheet (quarterly, 2025-12-31) — Inventory: 22639342.00
CTOR balance_sheet (quarterly, 2025-12-31) — Invested Capital: 62213812.00
CTOR cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4400000.00
CTOR cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 15125489.00
CTOR balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 3800111.00
CTOR balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3800111.00
CTOR cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 15125489.00
CTOR income_statement (quarterly, 2025-12-31) — Net Income: -5534069.00
CTOR income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -5534069.00
CTOR income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -5534069.00
CTOR income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -5534069.00
CTOR income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -5534069.00
CTOR cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -5534069.00
CTOR income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -5534069.00
CTOR cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -4400000.00
CTOR income_statement (quarterly, 2025-12-31) — Net Interest Income: -17553.00
CTOR income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -17553.00
CTOR balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -14412861.00
CTOR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 3049200.00
CTOR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3049200.00
CTOR income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -4650550.00
CTOR income_statement (quarterly, 2025-12-31) — Normalized Income: -5534069.00
CTOR cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -7354946.00
CTOR income_statement (quarterly, 2025-12-31) — Operating Income: -5252276.00
CTOR income_statement (quarterly, 2025-12-31) — Operating Revenue: 3944111.00
CTOR balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 84797846.00
CTOR income_statement (quarterly, 2025-12-31) — Other Gand A: 2859339.00
CTOR income_statement (quarterly, 2025-12-31) — Other Income Expense: -573438.00
CTOR balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 72826562.00
CTOR balance_sheet (quarterly, 2025-12-31) — Other Payable: 18250000.00
CTOR income_statement (quarterly, 2025-12-31) — Other Special Charges: 573438.00
CTOR balance_sheet (quarterly, 2025-12-31) — Payables: 40191478.00
CTOR balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 44710394.00
CTOR balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CTOR balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3162940.00
CTOR income_statement (quarterly, 2025-12-31) — Pretax Income: -5269829.00
CTOR cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -4400000.00
CTOR balance_sheet (quarterly, 2025-12-31) — Receivables: 4049111.00
CTOR income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 789208.00
CTOR income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 573438.00
CTOR income_statement (quarterly, 2025-12-31) — Research And Development: 1018352.00
CTOR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -69574025.00
CTOR income_statement (quarterly, 2025-12-31) — Salaries And Wages: 3956050.00
CTOR income_statement (quarterly, 2025-12-31) — Selling General And Administration: 6815389.00
CTOR balance_sheet (quarterly, 2025-12-31) — Share Issued: 84797846.00
CTOR income_statement (quarterly, 2025-12-31) — Special Income Charges: -573438.00
CTOR cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 3956050.00
CTOR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 58413701.00
CTOR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -14412861.00
CTOR income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CTOR income_statement (quarterly, 2025-12-31) — Tax Provision: 264240.00
CTOR income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CTOR balance_sheet (quarterly, 2025-12-31) — Total Assets: 109973406.00
CTOR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 62213812.00
CTOR balance_sheet (quarterly, 2025-12-31) — Total Debt: 3800111.00
CTOR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 58413701.00
CTOR income_statement (quarterly, 2025-12-31) — Total Expenses: 9196387.00
CTOR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 51559705.00
CTOR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 72826562.00
CTOR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6849311.00
CTOR income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -5252276.00
CTOR income_statement (quarterly, 2025-12-31) — Total Unusual Items: -573438.00
CTOR income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -573438.00